Brief: Virbac SA - H1 EBIT Adjusted EUR 144.2 Million
BRIEF-Virbac SA - H1 EBIT Adjusted EUR 144.2 Million Sept 17 (Reuters) - Virbac SA VIRB.PA:
VIRBAC H1 EBIT ADJUSTED EUR 144.2 MILLION
VIRBAC - REPORTS H1 2026 REVENUE GROWTH OF 7.4% AND ADJUSTED EBIT MARGIN OF 18.8% AT CERS
COMPANION ANIMAL SEGMENT UP 10.0%, FARM ANIMAL SEGMENT UP 6.7%, SUPERCHARGE PLATFORMS UP 12% AT CERS
NET DEBT AS OF JUNE 2026 UP TO €196 MILLION FROM €173 MILLION AS OF DEC 2025
2026 GUIDANCE CONFIRMED AT UPPER END: REVENUE GROWTH 5.5%-7.5% AT CERS, ADJUSTED MARGIN AROUND 17%
H1 INTEGRATION OF THYRONORM CONTRIBUTED AN ADDITIONAL 3.7 PERCENTAGE POINTS TO OVERALL SUPERCHARGE PLATFORM GROWTH
Source text: nGNEzTgRl
Further company coverage: VIRB.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Virbac SA
See all newsFrance's Virbac Q3 revenue rises on strength in Both Companion Animal, Farm Animal segments
Brief: Virbac Sees 2026 Targets At Upper End Of Range
Bernstein lifts Virbac to 'outperform', as Supercharge portfolio boosts margins
French and Benelux stocks-Factors to watch on September 18
Virbac confirms outlook as Supercharge platforms drive profit growth